This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sarepta Therapeutics Inc (SRPT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 73.55M 256.96M 187.66M 39.90M
Receivables 2.42M 3.53M 4.71M 3.63M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 35.04M 3.06M 1.53M 1.65M
Total Current Assets 247.80M 270.81M 193.91M 45.18M
Property, Plant & Equipment, Gross 58.40M 32.38M 20.10M 20.03M
Accumulated Depreciation & Depletion 19.90M 17.33M 16.71M 15.76M
Property, Plant & Equipment, Net 38.50M 15.05M 3.40M 4.26M
Intangibles 5.89M 5.04M 4.91M 4.76M
Other Non-Current Assets 2.84M 672.00K 2.78M 155.00K
Total Non-Current Assets 47.24M 20.76M 11.08M 9.18M
Liabilities & Shareholder Equity
Total Assets 295.03M 291.57M 204.99M 54.37M
Accounts Payable 12.41M 17.63M 7.53M 9.40M
Short Term Debt 98.00K 92.00K 89.00K 85.00K
Other Current Liabilities 1.18M 9.89M 65.22M 5.57M
Total Current Liabilities 36.87M 35.97M 78.89M 20.60M
Long Term Debt 3.74M 1.58M 1.67M 1.76M
Deferred Income Taxes 6.78M 6.84M 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 760.00K 993.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 10.51M 8.41M 2.43M 2.75M
Total Liabilities 47.38M 44.38M 81.31M 23.35M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 247.65M 247.19M 123.68M 31.02M
Common Par 4.00K 4.00K 3.00K 13.00K
Additional Paid In Capital 926.77M 790.42M 554.93M 340.97M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -679.02M -543.24M -431.25M -309.96M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -95.00K 0.00 0.00 0.00
Total Capitalization 251.39M 248.77M 125.35M 32.77M
Total Equity 247.65M 247.19M 123.68M 31.02M
Total Liabilities & Stock Equity 295.03M 291.57M 204.99M 54.37M
Total Common Shares Outstanding 41.31M 37.75M 31.70M 22.62M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 40.03M 33.85M 23.60M 21.60M
Diluted Weighted Shares Outstanding 40.03M 33.85M 23.60M 21.60M
Number of Employees 204 146 103 98
Number of Part-Time Employees 0 0 0 0
SRPT News

SRPT Sarepta Therapeutics Inc

Analysts Ratings for SRPT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 6 4
Moderate Buy 1 1 0 0
Hold 10 10 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SRPT ANALYST REPORT

Brokerage Partners

SRPT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs